Bicycle Therapeutics (BCYC) EPS (Basic) (2018 - 2026)
Bicycle Therapeutics' (BCYC) quarterly EPS (Basic) came in at -$0.72 in Q2 2026, up 36.75% YoY from -$0.53 in Q2 2025, and up 17.39% on a QoQ basis from -$0.87 in Q1 2026.
Bicycle Therapeutics (BCYC) EPS (Basic) (2018 - 2026) Analysis & Trends
Bicycle Therapeutics (BCYC) has 9 years of EPS (Basic) data on file, last reported at -$0.72 in Q2 2026.
- Quarterly EPS (Basic) rose 36.75% year-over-year to -$0.72 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$2.73 (up 22.06% YoY) and the FY2025 annual result came in at -$3.16, down 8.84% from the prior year.
- EPS (Basic) advanced to -$0.72 in Q2 2026, from -$0.87 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.29 in Q4 2025 to a low of -$1.41 in Q2 2023.
- A 5-year average of -$0.94 and a median of -$0.9 in 2022 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) tumbled 62.96% — and 2025, when it soared 67.34%.
- Tracing BCYC's EPS (Basic) over 5 years: stood at -$1.01 in 2022, then slumped by 36.49% to -$1.38 in 2023, then soared by 35.42% to -$0.89 in 2024, then soared by 67.34% to -$0.29 in 2025, then plunged by 147.86% to -$0.72 in 2026.
- The last three EPS (Basic) figures came in at -$0.72 (Q2 2026), -$0.87 (Q1 2026), and -$0.29 (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Bicycle Therapeutics | 272.28 Mn | 272.28 Mn | - | -0.72 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.72 |
| Mar 31, 2026 | -0.87 |
| Dec 31, 2025 | -0.29 |
| Sep 30, 2025 | -0.85 |
| Jun 30, 2025 | -1.14 |
| Mar 31, 2025 | -0.88 |
| Dec 31, 2024 | -0.89 |
| Sep 30, 2024 | -0.74 |
| Jun 30, 2024 | -0.77 |
| Mar 31, 2024 | -0.62 |
| Dec 31, 2023 | -1.38 |
| Sep 30, 2023 | -1.26 |
| Jun 30, 2023 | -1.41 |
| Mar 31, 2023 | -1.30 |
| Dec 31, 2022 | -1.01 |
| Sep 30, 2022 | -0.96 |
| Jun 30, 2022 | -0.90 |
| Mar 31, 2022 | -0.93 |
| Dec 31, 2021 | -0.72 |
| Sep 30, 2021 | -0.59 |